Correlation Between Armata Pharmaceuticals and Biocardia
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and Biocardia, you can compare the effects of market volatilities on Armata Pharmaceuticals and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and Biocardia.
Diversification Opportunities for Armata Pharmaceuticals and Biocardia
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Armata and Biocardia is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and Biocardia go up and down completely randomly.
Pair Corralation between Armata Pharmaceuticals and Biocardia
Given the investment horizon of 90 days Armata Pharmaceuticals is expected to generate 0.57 times more return on investment than Biocardia. However, Armata Pharmaceuticals is 1.75 times less risky than Biocardia. It trades about 0.05 of its potential returns per unit of risk. Biocardia is currently generating about -0.02 per unit of risk. If you would invest 145.00 in Armata Pharmaceuticals on September 2, 2024 and sell it today you would earn a total of 85.00 from holding Armata Pharmaceuticals or generate 58.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Armata Pharmaceuticals vs. Biocardia
Performance |
| Timeline |
| Armata Pharmaceuticals |
| Biocardia |
Armata Pharmaceuticals and Biocardia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Armata Pharmaceuticals and Biocardia
The main advantage of trading using opposite Armata Pharmaceuticals and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.The idea behind Armata Pharmaceuticals and Biocardia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Biocardia vs. Aerovate Therapeutics | Biocardia vs. Adagene | Biocardia vs. Acrivon Therapeutics, Common | Biocardia vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |